Alto Neuroscience, Inc. (ANRO) Stock Forecast & Price Target
Alto Neuroscience, Inc. · NYSE
$27.39-0.48 (-1.72%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 8 firms covering Alto Neuroscience, Inc, 7 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $24.00 to $50.00 (about 2.1x), a sign of real disagreement on valuation. The average target of $33.86 sits 24% above the current $27.39. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 6 to 7 over recent months. On the fundamentals, the Street sees revenue growth near 0% this year and 0% next, consensus EPS building from about $-0.80 next quarter toward $-3.43 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 ratings
Moderate Buy
Strong Buy00%
Buy788%
Hold113%
Sell00%
Strong Sell00%
Based on 8 analysts giving stock ratings to Alto Neuroscience, Inc.
As of Jul, 7 of 8 firms rate ANRO a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ANRO EPS & revenue forecast
EPS · NEXT QUARTER
$-0.80
Range $-1.09 – $-0.60 · 6 analysts · +54% YoY
Next period, 6 analysts expect Alto Neuroscience, Inc. to earn $-0.80 a share (range $-1.09 – $-0.60), versus $-0.52 a year earlier. Full-year consensus is $-3.15, growing to $-3.43 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 6 analysts · +0% YoY
Revenue is expected to reach $0 (range $0 – $0), +0.0% year-over-year. Full-year consensus is $0, rising to $0 next year.
Top analysts covering Alto Neuroscience, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ANRO.
#1
Laura Chico
Wedbush · Rank #122
Hold
$24.00-12.4% to target
Overall win rate
40%
+ Follow
#2
Keay Nakae
Chardan Capital · Rank #130
Buy
$30.00+9.5% to target
Overall win rate
41%
+ Follow
#3
Patrick R. Trucchio
HC Wainwright & Co. · Rank #203
Buy
$50.00+82.5% to target
Overall win rate
35%
+ Follow
#4
TA
Tazeen Ahmad
B of A Securities · Rank #275
Buy
$35.00+27.8% to target
Overall win rate
41%
+ Follow
#5
Brian Skorney
Baird
Buy
$36.00+31.4% to target
Coverage
—
+ Follow
ANRO stock forecast FAQ
What is ANRO's average 12-month price target?+
The 7 analysts with a live target average $33.86 for Alto Neuroscience, Inc. over the next 12 months, ranging from a $50.00 high to a $24.00 low.
Is ANRO stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 8 analyst ratings, 7 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ANRO?+
The Street-high target is $50.00 (HC Wainwright & Co.), and the Street-low is $24.00 (Wedbush). The average of all 7 active targets is $33.86.
How many Wall Street analysts cover ANRO?+
8 analysts have an active rating on Alto Neuroscience, Inc., and 7 firms carry a live 12-month price target.
Who is the most accurate analyst covering ANRO?+
Among analysts who currently cover ANRO, Laura Chico of Wedbush has the strongest overall Quantellect track record (Rank #122). Their current call is Hold with a $24.00 target.
What is Alto Neuroscience, Inc.'s projected EPS for next quarter?+
The consensus estimate is $-0.80 per share (range $-1.09 – $-0.60) across 6 analysts. Full-year EPS is projected at $-3.15, rising to $-3.43 the following year.
How much revenue is Alto Neuroscience, Inc. expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading ANRO lately?+
As of Jul, 7 of 8 firms rate ANRO a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ANRO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
